22 hours BioCryst Pharmaceuticals (BCRX) Reports Q3 Loss, Tops Revenue EstimatesZacks

BioCryst (BCRX) delivered earnings and revenue surprises of 0% and 2.01%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Pharmaceuticals

22 hours BioCryst Pharmaceuticals (BCRX) Reports Q3 Loss, Tops Revenue EstimatesZacks

6 hours What the vote means for corporate AmericaFinancial Times X

7 hours Supernus Pharmaceuticals, Inc. (SUPN) Q3 2024 Earnings Call TranscriptSeeking Alpha X

9 hours Vertex Pharmaceuticals (VRTX) Q3 2024 Earnings Call TranscriptThe Motley Fool X

9 hours Vertex Pharmaceuticals Incorporated 2024 Q3 – Results – Earnings Call PresentationSeeking Alpha X

9 hours Vertex Pharmaceuticals Incorporated (VRTX) Q3 2024 Earnings Call TranscriptSeeking Alpha X

10 hours Supernus (SUPN) Reports Q3 Earnings: What Key Metrics Have to SayZacks X

10 hours Supernus Pharmaceuticals (SUPN) Beats Q3 Earnings and Revenue EstimatesZacks X

15 hours BioCryst Pharmaceuticals (BCRX) Q3 2024 Earnings Call TranscriptThe Motley Fool X

21 hours BioCryst Pharmaceuticals, Inc. 2024 Q3 – Results – Earnings Call PresentationSeeking Alpha X

2 days Rezdiffra Gains Traction In NASH As Madrigal Pharmaceuticals Targets European ExpansionSeeking Alpha X

3 days ANI Pharmaceuticals Is Acting Like It Is Being AcquiredSeeking Alpha X

3 days Is Recursion Pharmaceuticals a Millionaire-Maker Stock?The Motley Fool X

4 days Recursion Pharmaceuticals (RXRX) Exceeds Market Returns: Some Facts to ConsiderZacks X

4 days Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target Raised to $441.00 at UBS GroupMarketBeat X

4 days Tarsus Pharmaceuticals (NASDAQ:TARS) Trading Up 8.5% – What’s Next?MarketBeat X

4 days Healthcare Investing Finding Growth Beyond PharmaceuticalsSeeking Alpha X

4 days Longboard Pharmaceuticals (NASDAQ:LBPH) Reaches New 1-Year High – Here’s What HappenedMarketBeat X

4 days Scotiabank Forecasts Strong Price Appreciation for Agios Pharmaceuticals (NASDAQ:AGIO) StockMarketBeat X

4 days Earnings Preview: ANI Pharmaceuticals (ANIP) Q3 Earnings Expected to DeclineZacks X

4 days Earnings Preview: Amneal Pharmaceuticals (AMRX) Q3 Earnings Expected to DeclineZacks X

4 days Madrigal Q3 Earnings Beat, NASH Drug Sales Drive Top Line, Stock UpZacks X

4 days Alnylam Q3 Loss In Line With Estimates, Revenues Miss, Stock DownZacks X

4 days Fennec Pharmaceuticals (FRX) Scheduled to Post Quarterly Earnings on ThursdayMarketBeat X

4 days Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Price Expected to Rise, Canaccord Genuity Group Analyst SaysMarketBeat X

4 days Amneal Pharmaceuticals (AMRX) Scheduled to Post Quarterly Earnings on FridayMarketBeat X

5 days Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Given Consensus Recommendation of “Moderate Buy” by AnalystsMarketBeat X

5 days Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?Zacks X

6 days Kiniksa Pharmaceuticals (NASDAQ:KNSA) Price Target Raised to $35.00MarketBeat X

6 days Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: Should You Buy?Zacks X

6 days Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Zacks X

6 days Avadel Pharmaceuticals plc (NASDAQ:AVDL) Short Interest UpdateMarketBeat X

6 days AMI Asset Management Corp Purchases Shares of 51,262 Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)MarketBeat X

6 days DekaBank Deutsche Girozentrale Acquires 31,283 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)MarketBeat X

6 days Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Given Average Rating of “Moderate Buy” by AnalystsMarketBeat X

6 days Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives Average Recommendation of “Buy” from AnalystsMarketBeat X

7 days Lexicon Pharmaceuticals (NASDAQ:LXRX) Shares Up 9.7% – Here’s WhyMarketBeat X

7 days Tarsus Pharmaceuticals (NASDAQ:TARS) Hits New 12-Month High – What’s Next?MarketBeat X

7 days EyePoint Pharmaceuticals (NASDAQ:EYPT) Trading Down 6.5% – Should You Sell?MarketBeat X

7 days Kiniksa Pharmaceuticals (NASDAQ:KNSA) Shares Gap Down – Should You Sell?MarketBeat X

7 days Recursion Pharmaceuticals (NASDAQ:RXRX) Trading Down 1.6% Following Insider SellingMarketBeat X

7 days Vertex Gears Up to Report Q3 Earnings: Is a Beat in the Cards?Zacks X

1 week 1 Nasdaq Stock Down 62% This Year That Could Double Your Money, According to a Wall Street AnalystThe Motley Fool X

1 week Semanteon Capital Management LP Buys Shares of 22,057 Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)MarketBeat X

1 week EyePoint Pharmaceuticals (EYPT) Soars 27.6%: Is Further Upside Left in the Stock?Zacks X

1 week Zacks.com featured highlights include Vertiv, Limbach, Atour Lifestyle and Catalyst PharmaceuticalsZacks X

1 week Vertex Pharmaceuticals (VRTX) Stock Drops Despite Market Gains: Important Facts to NoteZacks X

1 week Tina Marriott Sells 6,000 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) StockMarketBeat X

1 week Recursion Pharmaceuticals (NASDAQ:RXRX) Stock Price Up 5.1% – Here’s What HappenedMarketBeat X

1 week Regeneron to Report Q3 Earnings: What’s in the Offing?Zacks X

1 week Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading 9.1% Higher – Time to Buy?MarketBeat X